CompletedN/Aketamine

Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time

Sponsored by University of New Mexico

NCT ID
NCT01567852
Target Enrollment
20 participants
Start Date
2011-08
Est. Completion
2013-03

About This Study

When undergoing ECT treatments, patient recovery time and re-orientation time may be shorter using ketamine for induction than using methohexital.

Conditions Studied

Post-anesthesia RecoveryOrientation

Interventions

  • Ketamine
  • Methohexital

Eligibility

Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* All patients eligible for ECT with a primary mood disorder (bipolar disorder, major depressive disorder) will be eligible to participate in this study. - Patients must have decisional capacity and must be able to consent for this study.

Exclusion Criteria:

* patients with a primary psychotic disorder (schizophrenia, schizoaffective disorder); patients designated as having an American Society of Anesthesiologist (ASA) Status of greater than 3;
* patients with a known allergic reactions to methohexital , ketamine and succinylcholine;
* patients with current or previous history of aneurysms, intracranial bleeds, or intracranial hypertension;
* patients with uncontrolled severe hypertension.

Study Locations (1)

University of New Mexico
Albuquerque, New Mexico, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source